Biocartis Raises €10 Million
Biocartis SA, a Swiss molecular and immunodiagnostics startup, has raised €10 million in Series A funding. Aescap Venture led the round, and was joined by Biovest, KBC Private Equity, Advent Venture Partners and seed backer Benaruca.
15 October 2009•3 mins read
